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Introduction: Studies have shown important gender differences among drug (including crack) users related to:
drug use patterns; health risks and consequences; criminal involvement; and service needs/use. Crack use is
prevalent in Brazil; however, few comparative data by sex exist. We examined and compared by sex key drug use,
health, socio-economic indicators and service use in a bi-city sample of young (18–24 years), regular and marginalized
crack users in Brazil.
Methods: Study participants (total n = 159; n = 124 males and n = 35 females) were recruited by community-based
methods from impoverished neighborhoods in Rio de Janeiro and Salvador. Assessments occurred by an anonymous
interviewer-administered questionnaire and serum collection for blood-borne virus testing between November 2010
and June 2011. Descriptive statistics and differences for key variables by sex were computed; in addition, a ‘chi-squared
automatic interaction detector’ (‘CHAID’) analysis explored potential primary factors differentiating male and female
participants.
Results: Most participants were non-white, and had low education and multiple income sources. More women had
unstable housing and income from sex work and/or panhandling/begging, whereas more men were employed. Both
groups indicated multi-year histories of and frequent daily crack use, but virtually no drug injection histories. Men reported
more co-use of other drugs. More women were: involved in sex-for-drug exchanges; Blood-Borne Virus (BBV) tested and
HIV+. Both groups reported similar physical and mental health patterns; however women more commonly utilized social
or health services. The CHAID analysis identified sex work; paid work; begging/panhandling; as well as physical and mental
health status (all at p < 0.05) as primary differentiating factors by sex.
Conclusions: Crack users in our study showed notable differences by sex, including socio-economic indicators,
drug co-use patterns, sex risks/work, BBV testing and status, and service utilization. Results emphasize the need
for targeted special interventions and services for males and female crack users in Brazil.
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Research has documented a number of important differ-
ences between male and female users of – both licit and
illicit – substances. While for many substance categories,
women typically feature lower prevalence levels of use
and problems than men, there appear to be some im-
portant differences in pathways to problems [1,2]. For
example, several key studies document that women
more quickly progress from use onset to problematic
use (‘telescoping’), including manifested substance use
disorders or need for treatment [3-5].
Women develop more severe medical or health prob-
lem consequences from substance use than men [6,7].
While women are typically less involved in substance
use-related overt deviance (e.g., violence or crime), data
from several studies suggest higher levels of co-morbid psy-
chological or psychiatric problems among women users;
specifically, large (30%–50%) proportions of women sub-
stance users report a history of (sexual or other) trauma
and/or related Post-traumatic stress disorder (PTSD)
[1,2,8]. In addition, larger proportions of women indicate
co-morbid mood (e.g., depression) and/or anxiety disorders;
however, the evidence is inconsistent about the directional-
ity or sequence of these co-morbidities [1,9-11].
Data suggests that biology-related sex differences may
influence differential drug use or problem patterns; for
example, women may be more vulnerable to the reinfor-
cing effects of psycho-stimulants during key develop-
mental phases leading to dependence [12]. Women
appear to enter substance use treatment less frequently
than men, but commonly enter treatment driven by
different factors (e.g., related to child care concerns),
implying differential treatment needs. While a lack of
targeted services for women drug users has been de-
scribed for several countries, gender does not seem to
majorly affect treatment retention, completion or out-
comes [5,13-17].
Crack users are a specific population of substance
users for which distinct gender differences have been re-
ported. Many female users report initiation into crack
use by an intimate partner, and use patterns and risks
are commonly shaped by the power dynamics within an
intimate relationship with a drug-using partner [18,19].
Women crack users commonly report more frequent or
problematic (e.g., ‘bingeing’) crack use [20-22] as well as
substantially more pronounced sexual risk behaviors re-
lated to crack use; for example, they are more commonly
involved in sex work, and/or risky sexual behaviors (e.g.,
unprotected sex) in exchange for money or crack [23-28].
These gendered risk behavior patterns have translated into
a higher prevalence of sex-risk related health problems –
including higher prevalence of Blood-Borne Viruses (BBVs)
or Sexually Transmitted Diseases (STDs) – among female
crack user populations (e.g., Human ImmunodeficiencyVirus (HIV) and/or Hepatitis C Virus (HCV)) [22,29,30].
Overall, female crack users commonly feature lower self-
reported health status than their male counterparts [25,31];
however there do not seem to be major gender-differences
in treatment seeking, retention or outcomes [13,32].
Crack use has become a prevalent street drug use
phenomenon in Brazil in recent years, associated with
considerable health and social harms, as well as intensive
discussions about appropriate interventions [33-36]. While
previous estimates have been higher, a recent study esti-
mated a population of some 370,000 crack users in the 27
Brazilian capital cities [37]. Most users have been shown to
be young, socio-economically marginalized (e.g., poor/
unemployed) and under-housed; further, most surveys
typically only find a minority of crack users to be
women [37-39].
In studies of different crack user populations attending
in-patient or community-based treatment programs,
only small minorities were females [40-42], offering only
limited data on the distinct characteristics of female
users, or potential differences between male and female
users in Brazil. In a sample of pregnant crack users in
in-patient detoxification treatment, 25% reported fre-
quent daily crack use (>20 rocks per day); most had
poly-substance use (e.g., tobacco, alcohol, cannabis).
Close to half reported sex work, i.e. exchange of sex for
money or drugs (45%) and crime involvement (e.g., rob-
bery; 41%), and 15% were HIV-positive and 6% were
HCV-positive [43]. Some other studies reported high
prevalence of sex work and/or unsafe sex among female
crack users in Brazil. In a sample of crack users in in-
patient treatment, women were more likely to report sex-
work involvement (and related HIV transmission risks)
than men [44]. Community-based samples of crack users
in Salvador and São Paulo reported high levels of unsafe
sex and sex-for-money/drug-exchange activities as strat-
egies to obtain crack among female participants, some of
which also occurred in the distinct contexts of women
obtaining crack for their intimate partners [35,45-50]. The
pronounced sexual risk behavior patterns among female
crack users in Brazil are directly linked to highly elevated
transmission risk and prevalence of BBVs as well as expos-
ure to violence and victimization [43,49,51]. Recent data
suggest an increasing trend in the proportion of women
crack users presenting in local health care facilities, which
may either point to increasing use prevalence or increas-
ing service utilization [52]. While substantive investments
for substance use related health and treatment services
(e.g., CAPS-AD, Therapeutic Community funding) have
been made in Brazil, the need for special and targeted ser-
vices for women has been emphasized given their distinct
problem and needs profiles [35,43,44].
This paper examined gender-specific drug use, health,
socio-economic and service use characteristics – and
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males – among a community-recruited bi-site sample of
young, regular crack users in Brazil.
Methods
This study utilized data from a cross-sectional multi-site
study of regular street-involved crack users recruited
from impoverished neighborhoods in Rio de Janeiro
(e.g., Jacarezinho) and Salvador (e.g., Pelourinho, Calabar,
Ribeira, Fazenda Coutos and Valéria) with known extensive
crack user populations (see [39] for details). Recruitment
was facilitated by community-based contact persons (e.g.,
community workers) with direct access to the target
population who disseminated basic study information
to potential participants; study candidates were then
assessed for eligibility by study field staff based on a
brief screening protocol.
Eligibility criteria included: 1) crack use on three days +
per week in the last three months; 2) 18–24 years of age;
and 3) consent to participate in the full study protocol. In-
dividuals experiencing acute intoxication or mental health
problems, or displaying problematic behavior impeding
assessment were not included. If eligible, and following
written consent, study participants were assessed in a pri-
vate study space at one of the community-based local study
offices in either site.
A total of 175 (95 in Rio and 80 in Salvador) individ-
uals were screened for eligibility; 15 were excluded for
age or drug use criteria; a total of n = 160 study assess-
ments (81/79) were completed between November
2010 and June 2011. Assessments consisted of an
interviewer-administered questionnaire with 31 mainly
quantitative items on socio-demographic, health and
drug use characteristics, and service use/needs; in addition,
blood specimens were collected by venipuncture and subse-
quently tested for HBAg, anti-HBc total, anti-HBs, total
anti-HAV, anti-HCV, and anti-HIV using commercial en-
zyme immunoassays. All data and samples were sent to the
Oswaldo Cruz Foundation (FIOCRUZ, RJ) for processing
and analyses. Questionnaire data were scanned using
Teleform® procedures and manually quality-checked;
statistical analysis were conducted using STATA v.9.
One subject was excluded from analysis due to unspeci-
fied sex, resulting in a basic analysis sample of n = 159
(n = 124 males and n = 35 females). Descriptive analysis –
e.g., proportions for categorical variables, mean/median
values for continuous variables – for key variables of inter-
est were computed and reported by sex. Statistical tests for
differences between males and females (e.g., chi-squares for
categorical variables, t-tests for continuous variables with
p-value set at p < 0.05) were conducted.
Subsequently, a CHAID (‘Chi-squared automatic inter-
action detector’) algorithm was used to examine poten-
tial factors independently differentiating between malesand female study participants [53,54]. The CHAID ana-
lysis essentially constitutes a non-binary tree classifica-
tion method focusing on independent predictor factors
or ‘nodes’ of classification into a dependent characteris-
tic (here: sex). This occurs by a stepwise procedure in
which the most significant variable (the largest χ2) is
used to partition the sample into mutually exclusive sub-
groups. The cases in the emerging subgroups are further
partitioned by the next most significant variable related
to the dependent variable of interest, until there are no
more significant variables. All variables were considered
statistically significant at p-value <0.05. Cases with miss-
ing data for any of the variables examined (n = 6) were
excluded from the CHAID analysis, resulting in an ana-
lysis sample of n = 153. The software used for this ana-
lysis was SPSS v.19.
Considering the dichotomous dependent variable of
sex (male vs. female), the independent variables selected
were: Education (some elementary school or less vs.
completed elementary school or higher); housing status
(stable vs. unstable or homeless); formal or informal
work for income (yes vs. no); illegal activities for income
(yes vs. no); begging/panhandling for income (yes vs.
no); sex work for income and/or source to obtain drugs
(yes vs. no); alcohol use (yes vs. no); marijuana use (yes
vs. no); cocaine use (yes vs. no); daily crack use (yes vs.
no); overdose (yes vs. no); sharing crack paraphernalia
(yes vs. no); unprotected sex (yes vs. no); HIV (serology)
status (positive vs. negative); Hepatitis A status (reagent
vs. non-reagent); Hepatitis B status (reagent vs. non-
reagent); Hepatitis C status (reagent vs. non-reagent);
physical health status (‘good’ or better vs. ‘fair’ or worse);
mental health status (‘good’ or better vs. ‘fair’ or worse);
arrest (yes vs. no). Except for 'education' and ‘arrest’ (in past
year), the reference period for all variables was ‘in past
30 days’ prior to the assessment.
The study protocol was approved by the Ethical Review
Committee, Institute of Psychiatry, Federal University of
Rio de Janeiro as well as the Brazilian National Ethics
Committee (CONEP 519/2010).
Results
Mean age of the samples was 21 years (range 18–24;
Standard Deviation [SD] + 2.2) for females, and 22 years
(18–24; SD 2.1) for males. Most respondents were of
non-white (i.e., black or mixed) race, single and had
some elementary school or less education. Significantly
more females than males were characterized by unstable
housing or homelessness. Close to half of men, and one
third of females had been arrested in the past year. Both
men and women had a variety of income sources; while
the most common income sources for men were em-
ployment or some sort of paid work, more women relied
on sex work and/or begging/panhandling for income
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payments less common for both sexes (Table 1).
Participants had an average history of 4 (SD: 3.0;
males) and 5 (SD: 3.4; females) years of crack use, and
used an average of 10 (SD: 11) and 8 (SD: 6) rocks of
crack per day, respectively. The majority of both males
and females were current tobacco users; while men also
commonly reported current use of marijuana, alcohol or
cocaine, women reported lower use prevalence of these
drugs. The use of other drugs was either marginally
small or non-existent (Table 2).
Very few participants reported a lifetime injection drug
history, or a recent overdose experience. While major-
ities of both males and females reported unsafe sex ac-
tivities, more females had recent sex-for-drug/money
exchanges. More women had been tested for HIV and
HCV; almost five times as many women as men were
determined to be HIV+. Close to half of both men and
women rated their physical health as ‘good’ or better.
Similar rates reported physical health problems; most of
those with problems did not receive medical attention
yet would have liked to do so. Similar patterns emerged
for mental health, except that more men than womenTable 1 Socio-demographic characteristics, employment statu
Age
Race
White
Non-White/Other
Marital Status
Single/separ/div/widow
Married or cohabitating
Educationa
Some elementary school or less
Completed elementary school or higher
Housing statusa [30]
Stable housing
Unstable housing or homeless
Income sources [30]
Formal or informal transfers (e.g., social assistance, money from family/friends
Paid employment/work
Illegal activities (including drug-related work)
Sex work
Begging/panhandling
Arrest history
Detained by police (past year)
*p < 0.05, **p < 0.01, ***p < 0.001.
aSubjects with missing data not included. [30]: in the last 30 days.rated their mental health as ‘good’ or better. Twice as
many women recently utilized any kind of social, health
or treatment service; social services were most commonly
used, followed by health and treatment services, respect-
ively. Substantive majorities among both sub-groups indi-
cated that they would use specific help services for drug
users if available to them (Table 3).
In the results of the CHAID analysis (Figure 1), the
most important variable differentiating male and female
participants was sex work for income and/or to get
drugs (p < 0.000). Among the individuals involved in sex
work, male respondents more frequently than females re-
ported involvement in formal/informal work (p = 0.017).
Among participants without sex work involvement, en-
gaging in begging/panhandling for income (p = 0.003)
emerged as the differentiating factor by sex. Among re-
spondents with begging for income, physical health
status (p = 0.011) was the main differentiating factor by
sex; among respondents not involved in begging, for-
mal or informal work (p = 0.017), again, was the princi-
pal differentiating factor; finally, among respondents
who indicated neither begging nor formal/informal
work as income sources, mental health status (p =s, income generation and arrest history of sample, by sex
Men (n = 124)
mean (SD)
Women (n = 35)
mean (SD)
Test statistic t P-value
20.7(2.1) 21.6(2.2) 2.174*
N (%) N (%) χ2
0.3905 0.532
11 (9.0) 2 (5.7)
111 (91.0) 33 (94.3)
0.6712 0.413
100 (80.6) 26 (74.3)
24 (19.4) 9 (25.7)
0.1736 0.677
102 (82.3) 29 (85.3)
22 (17.7) 5 (14.7)
13.2492* 0.000
71 (57.7) 8 (22.9)
52 (42.3) 27 (77.1)
) 35 (28.2) 10 (28.6) 0.0016 0.968
82 (66.1) 6 (17.1) 26.503*** 0.000
25 (20.2) 4 (11.4) 1.396 0.237
3 (2.4) 16 (45.7) 48.627*** 0.000
19 (15.3) 14 (40.0) 10.107*** 0.001
56 (45.2) 11 (31.4) 2.111 0.146
Table 2 Crack and other drug use characteristics of sample, by sex
Men (n = 124) M (SD) Women (n = 35) M (SD) Test statistic t P-value
Number of years of crack use 4.0 (3.0) 4.9 (3.4) 1.547
Number of crack rocks used per typical day 10.1 (10.5) 8.3 (5.9) 0.925
N (%) N (%) χ2
Daily crack use [30] 66 (53.2) 24 (68.6) 2.617 0.106
Main modes of crack use
Smoking mixed crack and tobacco 7 (5.7) 2(5.7) 0.0002 0.988
Smoking mixed crack and marijuana 29 (23.4) 1 (2.9) 7.5154* 0.006
Smoking crack using a can 8 (6.5) 2 (5.7) 0.0252 0.874
Smoking crack using a plastic cup 50(40.3) 22 (62.9) 5.5941* 0.018
Smoking crack using a pipe 28(22.6) 8 (22.9) 0.00123 0.972
Shared crack smoking implements [30]a 72 (62.1) 21 (60.0) 0.0487 0.825
Other drug use [30]a
Alcohol 68 (55.7) 9 (25.7) 9.8100** 0.002
Tobacco 97 (78.2) 31 (88.6) 1.8614 0.172
Marijuana 88 (71.5) 18 (51.4) 4.9936* 0.025
Amphetamines or LSD 0 (0.0) 0 (0.0) - -
Cocaine 55 (45.8) 4 (11.4) 13.6049*** 0.000
Benzodiazepines 3 (2.4) 0 (0.0) 0.8702 0.351
Opioids 0 (0.0) 0 (0.0) - -
Inhalants/Solvents 4 (3.4) 2 (5.9) 0.4325 0.511
*p < 0.05, **p < 0.01, ***p < 0.001.
asubjects with missing data not included. [30]: in the last 30 days.
Bertoni et al. International Journal for Equity in Health 2014, 13:70 Page 5 of 11
http://www.equityhealthj.com/content/13/1/700.012) emerged as the main differentiating factor be-
tween males and females.
Discussion
Our study’s results revealed several key areas of differ-
ences between males and females in our bi-city sample
of young crack users in Brazil, with implications for in-
terventions and further research.
First, our findings – both from univariate and the
CHAID analyses – indicated key differences in income
generation behaviors between male and female partici-
pants. While most men reported some form of paid
work, the largest proportion of women reported involve-
ment in sex work and/or begging/panhandling for in-
come generation. These results extend findings from
several other studies with crack users elsewhere, suggest-
ing pronounced patterns of ‘gendering’ related to in-
come sourcing in this population. That is, while men are
more commonly involved in legal or illegal ‘work’ or
crime activities, women commonly rely on commercial
sex or other forms (e.g., begging/panhandling) of income
generation [24,26,55,56]. These patterns bring several
implications. First – while our data did not specify what
‘work’ concretely meant – the predominant exclusion of
women from more ordinary ‘work’ activities and primary
reliance on sex work or begging may entail an evenmore pronounced socio-economic ‘marginalization’ of
female users than is already generally the case for this
population [55,57,58]. These marginalization dynamics
may further negatively influence the risks and conse-
quences of drug use, as well as engagement with or
access to key basic (e.g., social or health) services and
interventions, and hence amplify the overall negative cir-
cumstances of women crack users. Second, our results
confirm findings of other studies from different jurisdic-
tions (including some from Brazil) documenting the
common and intensive involvement of female crack
users in sex work [43,51,59,60]. Sex work involvement
among female crack users is well documented to be
strongly associated with key health risks – e.g., unpro-
tected sex, unsafe sex practices, multiple sex partners,
acute BBV transmission, often occurring in the context
of crack use ‘binges’ – as well as exposure to violence
and related victimization [20,21,23,25,27,60]. Commonly,
commercial sex work among female crack users occurs
within the imbalanced power dynamics of intimate rela-
tions with male crack user partners, where women are
charged with procuring funds to acquire drugs for them-
selves and their partner [18,49]. Given the high prevalence
of sex work for income among female users and its key
consequences (see also below) in our sample, implementing
interventions to reduce sex work involvement and/or or
Table 3 Health risk, status and service utilization characteristics of sample, by sex
Men (n = 124) N (%) Women (n = 35) N (%) Test statistic χ2 p-value
Sexual Risks
Had sex without a condom [30] 75 (60.5) 22 (62.9) 0.0646 0.799
Had sex in exchange for drugs in [30] 5 (4.0) 10 (28.6) 19.2377*** 0.000
Health status
Drug overdose [30] 8 (6.5) 1 (2.9) 0.6257 0.429
Injection drug use (lifetime) 2 (1.6) 0 (0.0) 0.5717 0.450
Oral sores/injuries [30] 18 (14.8) 5 (14.3) 0.0048 0.945
Ever tested for HIV 27 (22.3) 26 (76.5) 34.5957*** 0.000
HIV + (serology) 5 (4.1) 6 (18.9) 7.8139** 0.005
Ever tested for Hep C 9 (7.6) 18 (60.0) 43.9874*** 0.000
Hep C + (HCVAB serology) 0 (−) 1 (3.0) 3.7210 0.054
Hep B serology 17 (13.9) 9 (28.1) 3.6379 0.056
Hep A serology 99 (81.2) 29 (90.6) 1.6227 0.203
Physical health problems [30] 52 (42.6) 16 (45.7) 1.0754 0.584
Received medical attentionb 7 (12.7) 5 (31.3) 3.0277 0.082
Would like to receive medical attentionb 40 (78.4) 12 (75.0) 3.1357 0.077
Self-rated physical healtha 0.5902 0.422
‘Good’ or better 49 (41.5) 12 (34.3)
Mental health problems [30] 58 (46.8) 15 (42.9) 0.8137 0.666
Received medical attentionb 1 (1.75) 0 (−) 0.2491 0.618
Would like to receive medical attentionb 38 (66.7) 10 (71.4) 0.1164 0.733
Self-rated mental health 4.4885* 0.034
‘Good’ or better 63 (52.9) 11 (32.4)
Service utilization
Accessed social, health or drug treatment services [30] 37 (29.8) 20 (57.1) 8.8485** 0.003
Type of service [30]c
Social services 24 (19.5) 16 (45.7) 9.8937** 0.002
Health services 12 (10.4) 8 (22.9) 4.2299* 0.040
Drug treatment service used [30] 3 (3.2) 2 (6.5) 0.6654 0.415
Would use service for DU’s, if available. 98 (79.0) 27 (77.1) 0.2578 0.879
*p < 0.05, **p < 0.01, ***p < 0.001.
amissing values.
bof those who reported problems.
Cincludes multiple responses. [30]: in the last 30 days
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tutes an urgent intervention need.
Second, our data indicate higher prevalence, and more
diversified patterns of (current) poly-drug use (including
alcohol, marijuana, and cocaine) among male than
among female crack users. These differences are notable,
in particular since – with the exception of cocaine co-
use – they are mostly absent when ‘lifetime’ histories for
these drugs (data not shown) are considered; moreover,
almost 4 in 5 women (twice as many compared to men)
reported a ‘lifetime’ history of inhalants/solvents. These
gendered co-drug use patterns – and specifically the more
pronounced current ‘mono’-crack use profiles amongfemales – point to a number of potential dynamics. The
drug use pathways into crack use may differ between males
and females; further, it is a worthwhile question whether
the disappearance of inhalant/solvent use among females is
mainly an ecologically driven or a ‘drug use career’ effect
[1,4]. While tobacco and marijuana are used by most fe-
male crack users (and have been shown in other crack user
populations to be used in combination with crack in order
to modify effects) [61,62], women may either not desire, or
may not have available or be able to afford the other drugs
– alcohol and/or cocaine – which were commonly co-used
by men. Additional inquiries – e.g., including qualitative/
ethnographic investigations – should investigate these
Figure 1 Results of chi-squared automatic interaction detector (CHAID) model for study sample with ‘sex’ as dependent outcome variable.
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sequences and intervention/treatment needs (e.g. in respect
to poly-dependence, physical co-morbidities, etc.) [4,63,64].
A third key area of differences concerns health risk
and status indicators. While men and women indicated
overall similar physical health profiles, the differences inBBV status – in particular HIV, with women reporting
elevated levels – are noteworthy. Since drug injecting
histories – the most common cause of HIV transmis-
sions among illicit drug users – are close to absent in
our study population, we must assume that most HIV
infections were caused by sexual transmission pathways
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mon involvement in sex work activities and associated
sexual risk behaviors among females in our sample con-
stituted a primary risk factor for increased BBV trans-
mission and status levels [35,45,51,59,66,67]. Studies
conducted elsewhere have found crack use to be an in-
dependent predictor of HIV and other BBV (e.g., HCV)
transmissions among drug user populations [68-71]. Our
data underscore the urgent need for targeted HIV and
other BBV prevention and treatment measures in the
study population, yet primarily among female crack users,
with a primary emphasis on sexual risk reductions. Exam-
ples of peer- or community-based interventions – e.g.,
outreach programs and/or brief cognitive-behavioral in-
terventions – aiming at sex-related risk behaviors among
female crack users have been implemented elsewhere with
positive results [72-75].
A further difference is related to the substantially
lower levels of self-rated mental health among female
participants. While these differences were not shown for
mental health ‘problems’, and while the self-assessment
of one’s own mental health status constitutes a subject-
ive exercise, somewhat higher levels of certain mental
health problem symptoms and/or disorders among fe-
male drug – including stimulant – users have been doc-
umented elsewhere; in particular, depression, anxiety
and PTSD symptom levels have been found to be higher
among female users [1,2,9,76]. These mental health
problems are commonly associated with stimulant mis-
use, and hence may burden female participants in our
study population more distinctly than men and, conse-
quently, lead to more intensive and/or problematic sub-
stance use behaviors [77-79]. While these data underscore
the need for interventions and care focusing on co-
occurring mental health problems among female crack
users, such problems are common among male users as
well and require general and integrated attention in tar-
geted services for the study population.
Finally, we found substantively higher social and health
service utilization rates – including higher HIV and
HCV testing rates – among female crack users in our
sample, [80]. While women in Brazil generally indicate
higher health service attendance, multiple possible ex-
planations and implications exist for these differences in
our study population [81]. Overall, our data seem to sug-
gest a somewhat – yet only partially closer – connection
and involvement of female crack users with care ser-
vices, which may suggest that women in our study’s local
contexts find these services more accessible or useful for
their needs (even though most services were utilized by
less than half of women, meaning that the majority of
women did not access any of these services). Previous
data has documented that – despite substantive recent
investments in and expansions of psycho-social andother treatment services for psychoactive drug users in
Brazil (e.g., CAPS-AD; [82]) – many crack users experi-
ence major barriers and problems with existent service
offers, and only few utilize or access them [33,83,84].
The observed sex-based differences in service utilization
may have other gender-specific reasons, e.g., higher use
of universal pre-natal care related services – including
sexual health and BBV testing – offered to women in
Brazil [51,85,86]. While the present study did not collect
relevant data to explain these dynamics in more detail, it
is documented that many female crack users in Brazil
have children, and thus pre-natal histories [35,37,43]. Fe-
male crack users may also be better connected to basic
(e.g., outreach) care through local services or interven-
tions specifically targeting sex workers [50,87,88].
Potential implications arise from these differential ser-
vice utilization profiles. Especially given the predominant
general ‘marginalization’ of crack users, improved con-
nections or involvement with social or health services
would likely allow for improved delivery of or referrals
to other – including general health, prevention or treat-
ment – services; this is much more difficult with drug
users who are completely disconnected from the service
system [57,89,90]. It is further documented that BBV (e.g.,
HIV, HCV) testing is important for both creating awareness
in regards to disease status and risk behavior changes, as
well as for initiating effective treatment among risk popula-
tions [91-95]. Thus, the observed differential service
utilization patterns between male and female crack users
ought to be better understood towards improved interven-
tion development and delivery.
Notably, the service utilization differences did not hold
for treatment utilization specifically, where less than one
in ten participants in both groups reported any recent
involvement. This may imply various reasons, including
lack of perceived need for treatment, limited availability
or access barriers; recent data have suggested that all of
these factors may be at work in the study population
[33]. While other studies have emphasized distinct treat-
ment and service needs for women drug users, it appears
– despite recent expansions of addiction treatment ser-
vices in Brazil – that major gaps in treatment offers, ac-
cess and utilization for crack users in Brazil in general
continue to exist which urgently ought to be addressed
[13,33,35,40,44,83]. This observation is supported by the
high proportion of (both male and female) users ex-
pressing desire to utilize improved service offers for drug
users if these were available.
Our study has several potential limitations. It relied on a
community-based convenience sample which may include
selection biases and compromise generalizability of results;
in addition, most data (except for biological tests) were
based on self-report which are not objectively verifiable;
however our study included key methodological provisions
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from service provision, etc.) for enhanced validity, and data
from similar study designs have shown to be valid [96].
The sample, and key data values reported, were rela-
tively small, potentially compromising analytical power.
The study protocol did not include clinical or diagnostic
assessments (e.g., for dependence) to formally assess
care (e.g., treatment) needs. The gender sub-samples
were comprised of participants from two different study
locations, where ecological or contextual differences (e.g.,
drug availability or costs, use cultures, service offers, etc.)
may have influenced individual behaviors or characteristics.
Conclusions
Our study documented several important differences in
drug use, health and service indicators between young
male and female crack users in Brazil. Given the preva-
lence of crack use in Brazil, these data illustrate the ur-
gent need for gender-specific interventions in several
(including targeted prevention, treatment) realms to-
wards reducing the extensive related health and social
problem burden of crack use.
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